Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,104 recruiting studies in this area right now.
By phase
- Not applicable4,205
- Phase 2592
- Phase 1413
- Phase 3328
- Phase 4254
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer225
- Endometrial Cancer210
- Bladder Cancer188
- Acute Kidney Injury134
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer112
- Chronic Kidney Disease108
- Infertility92
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension60
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama153
- Texas119
- Massachusetts117
- New York116
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,104 total
- NCT06320509Recruiting
Using urine oxygen to predict kidney recovery in shock
This study is testing if measuring oxygen levels in urine can help predict when kidney injury starts or gets better in ICU patients with shock. It aims to guide treatment earlier and avoid kidney damage.
AngersAges 18 years+ - NCT06319820RecruitingPhase 3
TAR-210 vs standard bladder chemo for FGFR-mutated bladder cancer
This trial compares a new drug, TAR-210, which is placed directly into the bladder, against standard chemotherapy given through a catheter. It is for people with a specific type of bladder cancer that has a change in the FGFR gene.
Little Rock, ArkansasAges 18 years+ - NCT06319963RecruitingPhase 1/Phase 2
Lenti-HPV-07 immunotherapy for HPV throat or cervical cancer
This trial tests a new immunotherapy called Lenti-HPV-07 for people with HPV-related throat or cervical cancer. It aims to help your immune system fight the cancer more effectively.
Orlando, FloridaAges 18 years+ - NCT06330064RecruitingPhase 1/Phase 2
Study of a new drug for advanced solid tumors
This study tests a new drug called Ifinatamab Deruxtecan (I-DXd) for people with several types of advanced cancer that has grown despite standard treatments. The drug is designed to target and attack cancer cells directly, potentially shrinking tumors or slowing their growth.
Los Angeles, CaliforniaAges 18 years+ - NCT06324045Recruiting
Deprescribing medicines for kidney disease patients
This study looks at whether carefully reducing or stopping some medicines (deprescribing) can help people with advanced kidney disease. The goal is to improve quality of life and avoid side effects from unnecessary medications.
DohaAges 18 years+ - NCT06332755RecruitingPhase 1
Study of LB-LR1109 alone and with atezolizumab for cancer
This trial tests a new drug called LB-LR1109, alone or with atezolizumab, for adults with certain advanced solid tumors, including non-small cell lung cancer. It's for people whose cancer has worsened after standard treatments or who cannot have those treatments.
Fairfax, VirginiaAges 18 years+ - NCT06329310Recruiting
Study of a new dialysis graft for kidney failure patients
This trial tests a new type of dialysis access graft (called aXess-E) for people with kidney failure who need a graft in their arm. It aims to see if the graft works well for long-term dialysis.
LisbonAges 18 years+ - NCT04500665RecruitingPhase 2
Colchicine for kidney-related heart inflammation
This Phase 2 trial tests whether colchicine can reduce inflammation and improve heart function in people with kidney disease and a certain type of heart problem. If you qualify, you’ll be closely monitored for side effects and lab changes.
Boston, MassachusettsAges 21–80 - NCT05197881Recruiting
Daily adaptive radiation for newly diagnosed cervical cancer
This study tests a radiation plan that is adjusted day by day to better match your cervix and surrounding tissues during treatment. It’s for newly diagnosed, advanced cervical cancer patients who will receive standard pelvic radiation and chemotherapy.
Burmingham, AlabamaAges 18 years+ - NCT05606133Recruiting
Test HPV DNA from blood to track cervical cancer risk
This study looks at a blood test that measures HPV DNA to help screen and monitor people with HPV-related cervical problems. If you have confirmed high-grade cervical changes or cervical cancer, the test may help doctors follow how your condition changes over time.
New York, New YorkAges 18 years+ - NCT06334315RecruitingPhase 4
Birth control pill study for healthy women
This study looks at how genes affect the way the body processes birth control pills. You take a low-dose pill for one cycle and have blood draws to measure hormone levels.
Aurora, ColoradoAges 18–45 - NCT06331468RecruitingPhase 2
Short-course radiation with chemo for advanced cervical cancer
This trial tests a shorter course of radiation combined with chemotherapy (hypofractionated radiochemotherapy) for women with advanced cervical cancer. It may help reduce treatment time while still effectively targeting the tumor.
Lexington, KentuckyAges 18–120 - NCT06331676Recruiting
Endometrial tissue model study for endometriosis care
This study creates a lab model of endometrial tissue from surgery samples to better understand and treat endometriosis. Researchers will collect tissue during your planned surgery (for endometriosis or another benign condition) to grow it in a dish and study it.
BronAges 18–50 - NCT06326905Recruiting
Transplant help for kidney waitlist patients with barriers
This study helps people on the deceased donor kidney waitlist who have had setbacks like health issues, lack of support, or low income. It offers extra support to help you get ready for transplant.
Baltimore, MarylandAges 18–99 - NCT06333340Recruiting
Comparing two medicines to prevent heavy bleeding after planned cesarean
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
Toronto, OntarioAges 18–50 - NCT06330480Enrolling by invitation
Screening for heart rhythm and kidney disease at home
This study is testing whether screening people at home can catch early signs of an irregular heartbeat (atrial fibrillation) and kidney disease. If you're in the right age group and live in one of the selected regions, you could join and help researchers learn more about spotting these conditions early.
AmsterdamAges 50–75 - NCT06329622RecruitingPhase 3
Does Ketosteril help muscle loss in kidney disease?
This study tests whether a medicine called Ketosteril can improve muscle strength and function in people with moderate to severe chronic kidney disease (CKD) who also have sarcopenia (age-related muscle loss).
ShanghaiAges Any age - NCT06319014Recruiting
Exercise to lower preeclampsia risk in pregnancy
This trial tests whether starting a physical activity program early in pregnancy can help lower your risk of preeclampsia, a serious condition. You must be less than 16 weeks pregnant, have a BMI between 18.5 and 45, and currently not be active.
Greenville, North CarolinaAges 18–40 - NCT06335017Recruiting
Castor oil and balloon for inducing labor in second-time moms
This study tests whether drinking castor oil combined with a balloon catheter can safely start labor in women who have given birth before. It may help avoid more medical interventions during labor induction.
NazarethAges 18–60 - NCT06325007Recruiting
Castor oil and balloon for labor induction in first-time mothers
This study tests whether taking castor oil before a balloon catheter helps start labor in first-time mothers. It may offer a simple option to begin labor when needed.
NazarethAges 18–60 - NCT06337565Recruiting
Safety of IBD drugs during pregnancy and breastfeeding
This study looks at how safe certain IBD medications are when taken during pregnancy and while breastfeeding. It follows mothers and their babies to check for any health effects.
Madrid, MadridAges 18–70 - NCT06330246Recruiting
Testing a gut bacteria treatment for calcium oxalate kidney stones
This study tests whether giving a specific gut bacteria can help people with calcium oxalate kidney stones. It looks at whether the bacteria can change how the body processes oxalate, which may reduce stone formation.
Birmingham, AlabamaAges 18–80 - NCT06335381Recruiting
Moms Chat and Care study for Black and Latina pregnant patients
This study tests a support program for Black and Latina pregnant people to help reduce pregnancy complications like preeclampsia. It uses text messaging and coaching to improve care and outcomes.
Manhasset, New YorkAges 18–50 - NCT06322732Recruiting
Better care for newborns with severe asphyxia at birth
This study looks at how routine hospital care for full-term or near-term newborns with severe oxygen deprivation at birth can be improved. It aims to find where care can be optimized to reduce complications.
Paris, Île-de-France RegionAges Up to 1 month
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,104 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 9,983 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.